- Type / Class
- Equity / Common Stock
- Shares outstanding
- 232,836,241
- Total 13F shares
- 24,994,636
- Share change
- -459,157
- Total reported value
- $7,317,322,181
- Put/Call ratio
- 115%
- Price per share
- $292.75
- Number of holders
- 729
- Value change
- -$157,075,084
- Number of buys
- 297
- Number of sells
- 415
Quarterly Holders Quick Answers
What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 036752103:
Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
23,019,518
|
$8,069,492,034 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.8%
|
17,694,658
|
$7,319,395,282 | $0 | 31 Mar 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
7.1%
|
16,601,224
|
$4,860,008,326 | $0 | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
10,341,466
|
$3,625,200,906 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
8,289,976
|
$2,906,051,086 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
7,446,185
|
$2,610,261,000 | — | 31 Dec 2025 | |
| Sanders Capital, LLC |
13F
|
Company |
2.5%
|
5,750,865
|
$2,015,965,726 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
5,124,599
|
$1,797,008,992 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.2%
|
5,032,751
|
$1,764,230,863 | — | 31 Dec 2025 | |
| HARRIS ASSOCIATES L P |
13F
|
Company |
2.1%
|
4,794,445
|
$1,680,692,576 | — | 31 Dec 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.7%
|
4,022,874
|
$1,410,218,523 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
3,903,878
|
$1,368,504,544 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
3,018,586
|
$1,058,165,322 | — | 31 Dec 2025 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
1.1%
|
2,531,090
|
$887,274,059 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
2,521,123
|
$883,780,825 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
2,408,704
|
$844,371,095 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1%
|
2,360,858
|
$827,598,772 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1%
|
2,347,771
|
$823,011,125 | — | 31 Dec 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.98%
|
2,275,342
|
$797,471,917 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.96%
|
2,231,428
|
$782,227,086 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.95%
|
2,207,140
|
$773,712,932 | — | 31 Dec 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.88%
|
2,051,150
|
$719,030,633 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.85%
|
1,977,899
|
$693,352,495 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.85%
|
1,975,317
|
$692,447,371 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.8%
|
1,866,369
|
$654,255,655 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
1,737,722
|
$609,158,447 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.72%
|
1,668,069
|
$584,741,588 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.68%
|
1,587,443
|
$556,477,332 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
1,560,432
|
$547,009,276 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.65%
|
1,516,792
|
$531,682,594 | — | 31 Dec 2025 | |
| EAGLE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.65%
|
1,504,051
|
$527,244,987 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.64%
|
1,479,271
|
$518,558,227 | — | 31 Dec 2025 | |
| Ruane, Cunniff & Goldfarb L.P. |
13F
|
Company |
0.61%
|
1,422,506
|
$498,659,478 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.58%
|
1,346,989
|
$472,186,994 | — | 31 Dec 2025 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
0.55%
|
1,269,302
|
$444,954,000 | — | 31 Dec 2025 | |
| Brave Warrior Advisors, LLC |
13F
|
Company |
0.54%
|
1,251,803
|
$438,819,542 | — | 31 Dec 2025 | |
| Orbis Allan Gray Ltd |
13F
|
Company |
0.53%
|
1,244,946
|
$436,415,820 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.47%
|
1,096,167
|
$384,261,342 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.44%
|
1,027,884
|
$360,325,112 | — | 31 Dec 2025 | |
| Newport Trust Company, LLC |
13F
|
Company |
0.43%
|
1,005,020
|
$352,309,761 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.41%
|
949,000
|
$332,671,950 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
889,836
|
$311,932,010 | — | 31 Dec 2025 | |
| Veritas Asset Management LLP |
13F
|
Company |
0.38%
|
873,993
|
$306,378,246 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.36%
|
838,758
|
$294,026,618 | — | 31 Dec 2025 | |
| Beutel, Goodman & Co Ltd. |
13F
|
Company |
0.35%
|
817,896
|
$286,713,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.35%
|
811,464
|
$284,458,706 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.34%
|
785,916
|
$275,502,854 | — | 31 Dec 2025 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.33%
|
762,196
|
$267,187,808 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
633,354
|
$222,024,069 | — | 31 Dec 2025 | |
| M&G Plc |
13F
|
Company |
0.27%
|
628,980
|
$220,771,980 | — | 31 Dec 2025 |
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2026
As of 31 Mar 2026,
Elevance Health, Inc. - Common Stock (ELV) was held by
729 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,994,636 shares.
The largest 10 holders included
Bank of New York Mellon Corp, Nuveen, LLC, DIMENSIONAL FUND ADVISORS LP, DEUTSCHE BANK AG\, SG Americas Securities, LLC, UBS Group AG, Swiss National Bank, Sumitomo Mitsui Trust Group, Inc., DAVENPORT & Co LLC, and HSBC HOLDINGS PLC.
This page lists
729
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1,533
Q1 2026 holders
729
Holder diff
-804
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.